Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 2
Submit an article Journal homepage
1,392
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings

Sabina Chiarettia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyCorrespondence[email protected]
View further author information
,
Akram Taherinasaba Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Irene Della Starzaa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, Italy;b Fondazione GIMEMA Onlus, Rome, ItalyView further author information
,
Martina Canichellaa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Michela Ansuinellia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Maria Stefania De Proprisa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Monica Messinab Fondazione GIMEMA Onlus, Rome, ItalyView further author information
,
Orietta Spinellic Haematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, BergamoView further author information
,
Alessandra Santorod Department of Hemato Oncology, AOR “VillaSofia-Cervello”, Palermo, ItalyView further author information
,
Lucia Anna De Novia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Deborah Cardinalia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Mattia Schipanie Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, ItalyView further author information
,
Valentina Arenab Fondazione GIMEMA Onlus, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-2782-2752View further author information
ORCID Icon,
Renato Bassanf Division of Hematology, Ospedale dell’Angelo, Mestre, Venezia, ItalyORCID Iconhttps://orcid.org/0000-0001-8214-2894View further author information
ORCID Icon,
Anna Guarinig Department of Molecular Medicine, “Sapienza” University of Rome, ItalyView further author information
&
Robin Foàa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
 show all
Pages 483-486 | Received 31 Aug 2022, Accepted 27 Oct 2022, Published online: 19 Dec 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.